Dental Treatment and TMJ on Lien: Jaw Injuries and Pharmacy in PI Cases

James Wong — Founder & Pharmacist, LienScripts | July 23, 2025 | 8 min read

Jaw injuries and temporomandibular joint disorders are common in front-impact and rear-impact vehicle accidents. Dental treatment and TMJ care can be provided on lien — and pharmacy lien coverage for the anti-inflammatory medications and muscle relaxants that manage TMJ pain and jaw inflammation completes the treatment record.

Jaw Injuries in Vehicle Accidents: More Common Than Recognized

Temporomandibular joint disorders and dental trauma following vehicle accidents are often overlooked in the initial post-accident evaluation — and in PI practice. The jaw is vulnerable in vehicle accidents for two primary mechanisms: direct impact to the facial region, and the rapid acceleration-deceleration forces that jolt the jaw relative to the skull even without direct contact.

TMJ dysfunction produces a characteristic cluster of symptoms: jaw pain and tenderness, clicking or popping with jaw movement, difficulty opening the mouth fully, pain with chewing, ear pain (referred from the TMJ), facial pain, and headaches — particularly temporal headaches that originate from the muscles of mastication.

In front-impact accidents, facial trauma can produce direct dental injury: cracked or fractured teeth, periodontal ligament injury, dental avulsion, and jaw contusions. In rear-impact accidents, the rapid flexion-extension forces that cause cervical injury can simultaneously produce TMJ joint injury and masticatory muscle strain.

These injuries are real, they're documentable, and they're increasingly recognized as legitimate PI injury components.

[!KEY] TMJ injuries are vulnerable to the "pre-existing" defense — a pharmacy record showing anti-inflammatory and muscle relaxant prescriptions beginning in the days after the accident establishes the treatment timeline that ties the onset of symptoms directly to the collision.

Dental Treatment and TMJ Care on Lien

Dental treatment on lien for personal injury is available through dental providers who understand the PI process. The scope includes:

Emergency Dental Care

Cracked, fractured, or avulsed teeth require prompt dental intervention — splinting, extraction, or temporary restoration. These are acute-phase injuries with clear timestamps (the accident) and clear causation. Emergency dental care on lien allows the patient to receive necessary treatment without delay or upfront cost.

Dental Reconstruction

When dental trauma requires crowns, implants, or extensive restoration, dental reconstruction on lien allows the full treatment course to proceed. The dental records and documentation of reconstruction costs become part of the damages documentation at settlement.

TMJ Specialist Care

TMJ disorders are treated by dentists with specialized training in occlusal function, or by oral and maxillofacial surgeons in more severe cases. TMJ treatment on lien may involve occlusal splints (night guards), physical therapy for the jaw, trigger point injections, or arthrocentesis in severe cases. The specialist's records document the clinical findings, treatment course, and relationship between the accident and the TMJ condition.

[!KEY] Dental trauma and TMJ cases benefit from early pharmacy lien enrollment because the initial post-accident prescription — NSAIDs and muscle relaxants written within days of the collision — establishes the treatment onset timeline before defense counsel can raise pre-existing condition arguments.

Medications That Treat TMJ and Jaw Injury

Pharmacological management of TMJ disorder and jaw injury complements the dental and specialist care. The medications commonly prescribed are not exotic — they're the same anti-inflammatory and muscle relaxant medications used in other soft tissue PI cases, applied to the specific pathophysiology of the jaw.

NSAIDs

Meloxicam and other prescription NSAIDs are the foundational pharmacological treatment for TMJ inflammation. The temporomandibular joint, like any synovial joint, responds to trauma with an inflammatory response. Consistent anti-inflammatory medication management during the acute and subacute phases reduces pain, limits ongoing inflammation-driven joint damage, and enables the patient to participate in jaw physical therapy.

Muscle Relaxants

The muscles of mastication — masseter, temporalis, medial and lateral pterygoid — frequently go into spasm following TMJ injury. Muscle spasm in these muscles is responsible for a significant portion of the pain, limited opening, and referred headache symptoms that characterize TMJ disorder. Cyclobenzaprine reduces central muscle hyperactivity and directly addresses this spasm. For patients who cannot tolerate cyclobenzaprine's sedating effects, methocarbamol provides an alternative.

Topical Agents

Topical diclofenac gel applied to the preauricular region (directly over the TMJ) provides localized anti-inflammatory treatment without the systemic exposure of oral NSAIDs. For patients who cannot take oral NSAIDs due to GI sensitivities or medication interactions, topical diclofenac provides anti-inflammatory coverage through a different route.

Tricyclic Antidepressants for Chronic TMJ

In cases where TMJ disorder becomes chronic — with pain persisting beyond the expected acute healing period — low-dose amitriptyline is sometimes prescribed as an adjuvant analgesic. It addresses the central sensitization component of chronic TMJ pain while also improving the sleep disruption that frequently accompanies chronic pain conditions.

[!NOTE] Cyclobenzaprine for masseter spasm and meloxicam for TMJ inflammation are medications targeted to the specific pathophysiology of jaw injury — their presence in the pharmacy record tells a coherent clinical story about the treating physician's diagnosis and the nature of the injury.

TMJ Documentation in PI Cases

TMJ injuries present a documentation challenge in PI cases: the symptoms are partially subjective, the joint is not easily imaged, and there is often some baseline TMJ dysfunction in the general population that defense counsel may argue was pre-existing.

The pharmacy record strengthens TMJ documentation in several ways:

First, it establishes the timeline: prescription for anti-inflammatory and muscle relaxant treatment beginning in the days after the accident, continuing consistently through the treatment course, creates a treatment timeline that corroborates the onset of TMJ symptoms at the time of the accident.

Second, it provides independent clinical documentation: the prescribing physician separately evaluated the patient's TMJ condition and determined that ongoing pharmacological management was warranted. That determination, reflected in consistent prescription fills, is independent of the dentist's records and corroborates them.

Third, the medication specificity matters: a patient taking cyclobenzaprine specifically for masseter muscle spasm and meloxicam specifically for TMJ inflammation is receiving medications targeted to the specific pathophysiology of the jaw injury — which tells a coherent clinical story at settlement.

[!KEY] The dental record alone documents structural findings and treatment costs — the pharmacy record adds the independent clinical layer showing that a prescribing physician also evaluated the patient and determined pharmacological management of the same injury was necessary.

Combining Dental Lien and Pharmacy Lien Coverage

Dental treatment on lien and pharmacy lien coverage are independent arrangements that run concurrently. The dental provider holds the dental lien; LienScripts holds the pharmacy lien. Both are resolved at settlement from case proceeds.

For attorneys managing cases with dental trauma or TMJ, the combination of dental treatment records and pharmacy lien documentation creates a more complete treatment record than either alone. Visit how it works for enrollment details or for attorneys for settlement documentation.

The MERIT report at settlement includes the full medication dispensing record, organized for attorney use, covering all medications dispensed under the pharmacy lien including those prescribed for jaw and TMJ treatment.